Advertisement
UK markets close in 32 minutes
  • FTSE 100

    7,875.62
    +27.63 (+0.35%)
     
  • FTSE 250

    19,398.76
    +58.62 (+0.30%)
     
  • AIM

    744.69
    +1.57 (+0.21%)
     
  • GBP/EUR

    1.1681
    +0.0014 (+0.12%)
     
  • GBP/USD

    1.2450
    -0.0006 (-0.05%)
     
  • Bitcoin GBP

    51,073.57
    +1,777.32 (+3.61%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,051.23
    +29.02 (+0.58%)
     
  • DOW

    38,044.53
    +291.22 (+0.77%)
     
  • CRUDE OIL

    82.45
    -0.24 (-0.29%)
     
  • GOLD FUTURES

    2,390.40
    +2.00 (+0.08%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,834.72
    +64.70 (+0.36%)
     
  • CAC 40

    8,031.74
    +50.23 (+0.63%)
     

GlaxoSmithKline Stock’s June Performance

GlaxoSmithKline Stock’s June Performance

British multinational pharmaceutical company GlaxoSmithKline (GSK) divides its business into three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. As it is a British company, it reports its revenue in British pounds. The chart below shows GlaxoSmithKline’s revenue and EPS since Q1 2017, and analysts’ estimate for Q2 2018.